Heather Raymon

SVP, Research and Development, Artiva Biotherapeutics, Inc.

Companies

Artiva Biotherapeutics, Inc.SVP, Research and Development Jul 18, 2024 to now¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

May 19, 2026Sold 3,095 shares at $9.01 of Artiva Biotherapeutics, Inc.²
Feb 15, 2026Shares withheld for tax 1,521 shares at $4.00 of Artiva Biotherapeutics, Inc.³
Feb 15, 2026Granted 46,000 shares of Artiva Biotherapeutics, Inc.³
Dec 12, 2025Granted 67,253 shares of Artiva Biotherapeutics, Inc.⁴
Nov 15, 2025Shares withheld for tax 1,375 shares at $3.25 of Artiva Biotherapeutics, Inc.⁵
Aug 15, 2025Shares withheld for tax 1,639 shares at $2.75 of Artiva Biotherapeutics, Inc.⁶
May 15, 2025Shares withheld for tax 745 shares at $2.13 of Artiva Biotherapeutics, Inc.⁶
Feb 26, 2025Granted 33,350 shares of Artiva Biotherapeutics, Inc.⁷
Sep 12, 2024Granted 10,000 shares of Artiva Biotherapeutics, Inc.⁸

The numbers on this page point here. Each one links to the record it came from.